You are currently viewing a new version of our website. To view the old version click .
Journal: VaccinesVolume: 12Number: 784
Article: Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study
  • Authors:
  • Alessandra Vergori1,*,
  • Giulia Matusali2 and
  • Eleonora Cimini3
  • et al.
Link: https://www.mdpi.com/2076-393X/12/7/784

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Production Quality: High quality (printed in full color on glossy, 135g/m2 paper and 2x stitched)

Shipping Address

Billing Address

0 / 500
The order must be prepaid after it is placed.